Found: 25
Select item for more details and to access through your institution.
Reversing cancer immunoediting phases with a tumor-activated and optically reinforced immunoscaffold.
- Published in:
- Bioactive Materials, 2024, v. 35, p. 228, doi. 10.1016/j.bioactmat.2024.01.026
- By:
- Publication type:
- Article
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment.
- Published in:
- Medcomm: Biomaterials & Applications, 2024, v. 3, n. 1, p. 1, doi. 10.1002/mba2.70
- By:
- Publication type:
- Article
CRISPR/Cas gene editing and delivery systems for cancer therapy.
- Published in:
- WIREs: Nanomedicine & Nanobiotechnology, 2024, v. 16, n. 1, p. 1, doi. 10.1002/wnan.1938
- By:
- Publication type:
- Article
Tumor Environment Regression Therapy Implemented by Switchable Prune‐to‐Essence Nanoplatform Unleashed Systemic Immune Responses.
- Published in:
- Advanced Science, 2023, v. 10, n. 35, p. 1, doi. 10.1002/advs.202303715
- By:
- Publication type:
- Article
A Multivalent Personalized Vaccine Orchestrating Two‐Signal Activation Rebuilds the Bridge Between Innate and Adaptive Antitumor Immunity.
- Published in:
- Small Methods, 2023, v. 7, n. 10, p. 1, doi. 10.1002/smtd.202300019
- By:
- Publication type:
- Article
Multi‐Targeted and On‐Demand Non‐Coding RNA Regulation Nanoplatform against Metastasis and Recurrence of Triple‐Negative Breast Cancer.
- Published in:
- Small, 2023, v. 19, n. 23, p. 1, doi. 10.1002/smll.202207576
- By:
- Publication type:
- Article
Hierarchically tumor-activated nanoCRISPR-Cas13a facilitates efficient microRNA disruption for multi-pathway-mediated tumor suppression.
- Published in:
- Theranostics, 2023, v. 13, n. 9, p. 2774, doi. 10.7150/thno.81776
- By:
- Publication type:
- Article
Author Correction: Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Tumor Microenvironment‐Activated Hydrogel Platform with Programmed Release Property Evokes a Cascade‐Amplified Immune Response against Tumor Growth, Metastasis and Recurrence.
- Published in:
- Small, 2022, v. 18, n. 50, p. 1, doi. 10.1002/smll.202107061
- By:
- Publication type:
- Article
A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer.
- Published in:
- Theranostics, 2021, v. 11, n. 20, p. 9833, doi. 10.7150/thno.62449
- By:
- Publication type:
- Article
Hierarchically Responsive Tumor‐Microenvironment‐Activated Nano‐Artificial Virus for Precise Exogenous and Endogenous Apoptosis Coactivation.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 37, p. 1, doi. 10.1002/adfm.202104423
- By:
- Publication type:
- Article
A spontaneous multifunctional hydrogel vaccine amplifies the innate immune response to launch a powerful antitumor adaptive immune response.
- Published in:
- Theranostics, 2021, v. 11, n. 14, p. 6936, doi. 10.7150/thno.58173
- By:
- Publication type:
- Article
Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response.
- Published in:
- Advanced Science, 2021, v. 8, n. 13, p. 1, doi. 10.1002/advs.202100292
- By:
- Publication type:
- Article
Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response.
- Published in:
- Advanced Science, 2021, v. 8, n. 13, p. 1, doi. 10.1002/advs.202100292
- By:
- Publication type:
- Article
Multistage Sensitive NanoCRISPR Enable Efficient Intracellular Disruption of Immune Checkpoints for Robust Innate and Adaptive Immune Coactivation.
- Published in:
- Advanced Functional Materials, 2020, v. 30, n. 45, p. 1, doi. 10.1002/adfm.202004940
- By:
- Publication type:
- Article
A Powerful CD8<sup>+</sup> T-Cell Stimulating D-Tetra-Peptide Hydrogel as a Very Promising Vaccine Adjuvant.
- Published in:
- Advanced Materials, 2017, v. 29, n. 5, p. n/a, doi. 10.1002/adma.201601776
- By:
- Publication type:
- Article
Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo.
- Published in:
- International Journal of Nanomedicine, 2017, v. 12, p. 1499, doi. 10.2147/IJN.S124843
- By:
- Publication type:
- Article
Peritoneal adhesion prevention with a biodegradable and injectable N,O-carboxymethyl chitosan-aldehyde hyaluronic acid hydrogel in a rat repeated-injury model.
- Published in:
- Scientific Reports, 2016, p. 37600, doi. 10.1038/srep37600
- By:
- Publication type:
- Article
Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis.
- Published in:
- Scientific Reports, 2015, p. 16437, doi. 10.1038/srep16437
- By:
- Publication type:
- Article
Thermosensitive hydrogel containing dexamethasone micelles for preventing postsurgical adhesion in a repeated-injury model.
- Published in:
- Scientific Reports, 2015, p. 13553, doi. 10.1038/srep13553
- By:
- Publication type:
- Article
Curcumin-Encapsulated Polymeric Micelles Suppress the Development of Colon Cancer In Vitro and In Vivo.
- Published in:
- Scientific Reports, 2015, p. 10322, doi. 10.1038/srep10322
- By:
- Publication type:
- Article
Biodegradable and thermosensitive micelles inhibit ischemia-induced postoperative peritoneal adhesion.
- Published in:
- International Journal of Nanomedicine, 2014, v. 9, p. 727, doi. 10.2147/IJN.S55497
- By:
- Publication type:
- Article
Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic drug delivery, part 2: in vitro and in vivo toxicity evaluation.
- Published in:
- Journal of Nanoparticle Research, 2011, v. 13, n. 2, p. 721, doi. 10.1007/s11051-010-0071-7
- By:
- Publication type:
- Article
5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice.
- Published in:
- 2010
- By:
- Publication type:
- journal article
5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice.
- Published in:
- BMC Cancer, 2010, v. 10, p. 402, doi. 10.1186/1471-2407-10-402
- By:
- Publication type:
- Article